Efficacy of Acalabrutinib in Very Old or Frail Patients With Treatment-naïve or Relapsed/Refractory CLL
Clinical trial NCT04883749 · COMPLETED
Trial details
- NCT number
- NCT04883749
- Sponsor
- German CLL Study Group
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-06-01
- Primary completion
- 2025-05-08
- Enrollment
- 53
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.